- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-07-15
DOI
10.1038/s41598-020-68336-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammation and Immunity in IPF Pathogenesis and Treatment
- (2019) P. Heukels et al. RESPIRATORY MEDICINE
- A simple protocol for isolating mouse lung endothelial cells
- (2019) Jinping Wang et al. Scientific Reports
- Leukemic transformation among 1306 patients with primary myelofibrosis: risk factors and development of a predictive model
- (2019) Rangit R. Vallapureddy et al. Blood Cancer Journal
- Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling
- (2019) Subhendu Mukherjee et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Inhibiting eicosanoid degradation exerts antifibrotic effects in a pulmonary fibrosis mouse model and human tissue
- (2019) Thomas Bärnthaler et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support
- (2018) Amar Desai et al. HAEMATOLOGICA
- Idiopathic Pulmonary Fibrosis
- (2018) David J. Lederer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support
- (2018) Amar Desai et al. HAEMATOLOGICA
- Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
- (2017) Alexander V. Misharin et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Therapeutic targets in idiopathic pulmonary fibrosis
- (2017) Martin Kolb et al. RESPIRATORY MEDICINE
- Cellular senescence mediates fibrotic pulmonary disease
- (2017) Marissa J. Schafer et al. Nature Communications
- Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7
- (2017) J. Guiot et al. PLoS One
- Human lung fibroblasts produce proresolving peroxisome proliferator-activated receptor-γ ligands in a cyclooxygenase-2-dependent manner
- (2016) Shannon H. Lacy et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Transforming Growth Factor-β: Master Regulator of the Respiratory System in Health and Disease
- (2016) Yael Aschner et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- The anti-inflammatory effects of PGE2on human lung macrophages are mediated by the EP4receptor
- (2016) Sharonjit K Gill et al. BRITISH JOURNAL OF PHARMACOLOGY
- TGF-β: the master regulator of fibrosis
- (2016) Xiao-ming Meng et al. Nature Reviews Nephrology
- Neutrophil elastase promotes myofibroblast differentiation in lung fibrosis
- (2015) Alyssa D. Gregory et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration
- (2015) Y. Zhang et al. SCIENCE
- Reversal of Persistent Fibrosis in Aging by Targeting Nox4-Nrf2 Redox Imbalance
- (2014) L. Hecker et al. Science Translational Medicine
- Reversal of Myofibroblast Differentiation by Prostaglandin E2
- (2013) Garth Garrison et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- M1 and M2 Macrophages: Oracles of Health and Disease
- (2013) Charles Mills CRITICAL REVIEWS IN IMMUNOLOGY
- Transforming Growth Factor–β Evokes Ca2+Waves and Enhances Gene Expression in Human Pulmonary Fibroblasts
- (2012) Subhendu Mukherjee et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2
- (2012) Vera Ivanova et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- A neutrophil elastase inhibitor prevents bleomycin-induced pulmonary fibrosis in mice
- (2012) Akihiro Takemasa et al. EUROPEAN RESPIRATORY JOURNAL
- JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
- (2012) Claire Harrison et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Integrating mechanisms of pulmonary fibrosis
- (2011) Thomas A. Wynn JOURNAL OF EXPERIMENTAL MEDICINE
- Idiopathic pulmonary fibrosis
- (2011) Talmadge E King et al. LANCET
- Does Chronic Microaspiration Cause Idiopathic Pulmonary Fibrosis?
- (2010) Joyce S. Lee et al. AMERICAN JOURNAL OF MEDICINE
- New concepts of IL-10-induced lung fibrosis: fibrocyte recruitment and M2 activation in a CCL2/CCR2 axis
- (2010) Lei Sun et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Management of polycythaemia vera, essential thrombocythaemia and myelofibrosis with hydroxyurea*
- (2010) Eva Löfvenberg et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- 16,16-Dimethyl Prostaglandin E2Efficacy on Prevention and Protection from Bleomycin-Induced Lung Injury and Fibrosis
- (2008) Marco Failla et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started